Navigation Links
Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07,Teleconference to Answer Questions About TA-65, Their Telomerase,Activator With Proven Age Management Benefits

NEW YORK, June 15, 2007 /PRNewswire/ -- Telomerase Activation Sciences, Inc. (T.A. Sciences) recently announced the results of the Pivotal 2005 Anti-Aging Trial of TA-65, the first human trial ever to show demonstrated, measurable and positive anti-aging benefits from a Telomerase Activator. Statistically significant results were found in those taking TA-65 across several key conditions of aging:

    -- Improvement in immune system function

    -- Improvement in vision

    -- Enhancement of male sexual function

    -- Improvement in the condition of the skin

    -- Increased level of energy and sense of overall well being

The Pivotal 2005 Anti-Aging Trial was a double blind, placebo-controlled, 24 week study conducted in the USA involving 36 male subjects aged 60-85.

The most compelling result of the Trial was the profound and positive impact of TA-65 on the immune system, which normally declines with age, leading to many negative conditions commonly associated with aging.

Noel Thomas Patton, Founder and Chairman of TA Sciences said: "Taken together, the results of the Pivotal 2005 Anti-Aging Trial of TA-65 provide the first proof ever recorded of the vast, powerful, and tangible benefits of a Telomerase Activator in human aging. This trial has been invaluable to our establishment of the "PATTON PROTOCOL."

                        Find Out More on July 7, 2007


    On Saturday, July 7, 2007 at 6PM EST speakers include:


    -- Bill Andrews, Ph.D. Vice-President of research at Sierra Sciences Lab

       who, while Director of Molecular Biology at Geron Corporation was one

       of the principal discoverers of the telomerase genes.

    -- Jochen Kumm, Ph.D. Bio- Mathematics Director for the Stanford Genome

       Project.

    -- Physioage Medical Group Co-Founder Joseph Raffaele, M.D.

    -- TA Sciences founder Noel Patton.

The group will be disc ussing the details of the findings about TA-65 and answering caller questions. You can participate in this phone call at no cost, just by calling 1-866-463-5401 and entering a special code you can obtain by pre-registering at http://www.TASciences.com.

About TA Sciences:

The TA Sciences Center is located at 24 E. 64th Street in New York. The company offers its telomerase-activating molecule, TA-65, as part of the exclusive 12 month "PATTON PROTOCOL." TA-65 is sold under exclusive license from the Geron Corporation, the recognized worldwide leader in Telomere Biology.

CONTACT: TA Sciences, +1-212-588-8805

Web site: http://www.tasciences.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
2. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
3. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
4. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
5. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
6. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
9. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
10. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
11. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , February 12, 2016 /PRNewswire/ ... nicht anders vermerkt)   http://www.sedar.com ... http://www.telestatherapeutics.com abrufbar.    --> ... des Unternehmens http://www.telestatherapeutics.com abrufbar.    ... (TSX:TST; PNK:BNHLF) veröffentlichte heute seinen Konzernabschluss des ...
(Date:2/12/2016)... , Feb. 12, 2016  SI-BONE, Inc., a medical device company ... ("iFuse"), a minimally invasive surgical (MIS) device indicated for fusion for ... Services, Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... , Feb. 12, 2016  Memorial Hermann Health System ... Dwight Howard to bring a one-of-a-kind experience to ... Using cutting-edge technologies such as 360-degree video and Google ... virtually, then literally – giving the patients and their ... it was all caught on video . ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House ... Blue SKies Buddha, the biography of Rama - Dr. Frederick Lenz. , ... the love of a Buddhist teacher for teaching and helping others. Valentine’s Day ...
(Date:2/12/2016)... ... 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , Feb. 25, 2016 ... Winston Churchill said, “Those who don’t learn from history are doomed to repeat it.” , ... come knocking this year. But that takes time. , Take a close look at ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker ... Red Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and ... hydrated before the big event. The invitation-only gifting suite, held this year at the ...
(Date:2/12/2016)... ... February 12, 2016 , ... Every winter, someone is killed, ... the West Penn Burn Center, part of the Allegheny Health Network, has ... bring you the “Space Heaters Need Space” campaign. , “Space Heaters Need ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Vail knee ... Industry Physician Leaders to Know in 2016 . The list consists of physicians establishing, ... physicians to establish this list. , An Ambulatory Surgery Center, also known as ...
Breaking Medicine News(10 mins):